Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care.

Thomas, W; White, D; Cox-Morton, S; MacDonald, S; Besser, M

Thomas, W; White, D; Cox-Morton, S; MacDonald, S; Besser, M.

Afiliação

Thomas W; Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom. Electronic address: w.thomas1@nhs.net.
White D; Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Cox-Morton S; Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
MacDonald S; Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Besser M; Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.

Thromb Res ; 195: 226-227, 2020 11.

Article em En | MEDLINE | ID: mdl-32795720

Assuntos

Anticoagulantes; Infecções por Coronavirus; Heparina; Pandemias; Pneumonia Viral; Anticoagulantes/farmacologia; Anticoagulantes/uso terapêutico; Betacoronavirus; COVID-19; Cuidados Críticos; Heparina/uso terapêutico; Humanos; Incidência; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Heparina / Infecções por Coronavirus / Pandemias / Anticoagulantes Tipo de estudo: Incidence_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Thromb Res Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google